azomycin has been researched along with Breast Cancer in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (38.10) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Bielawska, A; Bielawski, K; Czarnomysy, R; Hermanowicz, JM; Muszyńska, A; Prokop, I; Radomska, D | 1 |
| Chen, A; Chen, S; Du, Z; Hao, Y; He, M; Huang, X; Lan, Y; Li, S; Liu, J; Long, S; Luo, S; Su, Y; Wang, C; Wang, H; Yang, D; Yu, S | 1 |
| Cao, Y; Hu, B; Li, M; Liu, X; Shi, L; Song, N; Yu, Z; Zhou, Z | 1 |
| Brocks, DR; Jans, HS; Kumar, P; Wiebe, LI; Wuest, M; Yang, XH | 1 |
| Saggar, JK; Tannock, IF | 1 |
| Gao, M; Huang, D; Jiang, C; Lou, B; Lu, X; Ni, Y; Peng, F; Ren, K; Wang, X; Yang, A; Yao, N; Zhang, J | 1 |
| Ahmad, Z; Chen, X; Lv, S; Shah, A; Tang, Z | 1 |
| Atkins, GJ; DeNichilo, M; Evdokiou, A; Findlay, DM; Hay, S; Ingman, W; Labrinidis, A; Liapis, V; Panagopoulos, V; Ponomarev, V; Zannettino, AC; Zinonos, I; Zysk, A | 1 |
| Bhandari, DR; Cheng, M; Glunde, K; Heeren, RM; Jiang, L; Mascini, NE; Podmore, H; Rizwan, A; Römpp, A | 1 |
| Beauduy, JL; Dornfeld, K; Gessert, CE; Knowles, DM; McDonald, BL; McNaney, DD; Renier, CM; Urias, RE; Widell, SL | 1 |
| Dische, S; Minchinton, A; Rich, TA; Saunders, MI; Stratford, MR | 1 |
| Bennett, MH; Dische, S; Hauck, J; Minchinton, AI; Riley, PJ; Saunders, MI; Stratford, MR | 1 |
| Kogelnik, HD; Mamoli, B; Reinartz, G; Seitz, W; Stark, H; Szepesi, T; Wessely, P; Wurst, F | 1 |
| Cherif, A; Harrod, VL; Inoue, T; Kim, CG; Kim, EE; Kuang, LR; Newman, RA; Nornoo, A; Podoloff, DA; Wallace, S; Yang, DJ | 1 |
| Hori, H; Inayama, S; Inomata, T; Kasai, S; Kuwasaka, H; Masui, M; Nagasawa, H; Oka, S; Oshodani, T; Uto, Y; Yamashita, M | 1 |
| Bleehen, NM; Watson, JV; Wiltshire, CR; Workman, P | 1 |
| Munzenrider, JE | 1 |
| Ash, DV; Bugden, RD; Smith, MR | 1 |
| Adams, GE; Dische, S; Flockhart, IR; Foster, JL; Gray, AJ | 1 |
| Erber, S; von Angerer, E | 1 |
| Bennett, MH; Dische, S; Orchard, R; Stratford, MR; Wardman, P | 1 |
1 review(s) available for azomycin and Breast Cancer
| Article | Year |
|---|---|
Recent advances in radiotherapy.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1977 |
2 trial(s) available for azomycin and Breast Cancer
| Article | Year |
|---|---|
Clinical studies with misonidazole.
Topics: Adult; Astrocytoma; Brain Neoplasms; Breast Neoplasms; Humans; Nitroimidazoles; Radiation-Sensitizing Agents; Random Allocation; Time Factors | 1978 |
Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations.
Topics: Adult; Aged; Biopsy; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Nervous System Diseases; Neurologic Examination; Nitroimidazoles; Radiation-Sensitizing Agents; Radiography; Sarcoma; Skull; Taste; Vomiting | 1976 |
18 other study(ies) available for azomycin and Breast Cancer
| Article | Year |
|---|---|
Evaluation of the Anticancer Activities of Novel Transition Metal Complexes with Berenil and Nitroimidazole.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagosomes; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cisplatin; Coordination Complexes; Diminazene; DNA; DNA Topoisomerases, Type II; Female; Gold; Humans; Membrane Potential, Mitochondrial; Mitochondria; Nitroimidazoles; Organometallic Compounds; Palladium; Platinum; Transition Elements; Xenograft Model Antitumor Assays; Zebrafish | 2020 |
Synthesis of Mitochondria-Anchored Nitroimidazoles with a Versatile NIR Fluorophore for Hypoxic Tumor-Targeting Imaging and Chemoradiotherapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carbocyanines; Chemoradiotherapy; Coloring Agents; Female; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Nitroimidazoles; Tumor Hypoxia | 2021 |
Noncanonical Amino Acids for Hypoxia-Responsive Peptide Self-Assembly and Fluorescence.
Topics: Alanine; Amino Acids; Animals; Breast Neoplasms; Cell Line, Tumor; Female; Fluorescent Dyes; Mice; Microscopy, Confocal; Nitroimidazoles; Nitroreductases; Optical Imaging; Peptides; Transplantation, Homologous | 2021 |
Positron Emission Tomography (PET) and Pharmacokinetics: Classical Blood Sampling Versus Image-Derived Analysis of [18F]FAZA and [18F]FDG in a Murine Tumor Bearing Model.
Topics: Animals; Breast Neoplasms; Disaccharides; Disease Models, Animal; Female; Kinetics; Mice; Mice, Inbred BALB C; Nitroimidazoles; Positron-Emission Tomography; Tissue Distribution | 2018 |
Activity of the hypoxia-activated pro-drug TH-302 in hypoxic and perivascular regions of solid tumors and its potential to enhance therapeutic effects of chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cell Hypoxia; Docetaxel; Doxorubicin; Female; Humans; Male; Mice; Mice, Nude; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Prostatic Neoplasms; Taxoids; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.
Topics: Animals; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mammary Neoplasms, Animal; Neovascularization, Pathologic; Nitroimidazoles; Phosphatidylinositol 3-Kinases; Rats; Signal Transduction; Stilbenes | 2015 |
Methoxy poly (ethylene glycol)-block-poly (glutamic acid)-graft-6-(2-nitroimidazole) hexyl amine nanoparticles for potential hypoxia-responsive delivery of doxorubicin.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Survival; Doxorubicin; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Hypoxia; MCF-7 Cells; Micelles; Nanoparticles; Nitroimidazoles; Polyglutamic Acid; Proton Magnetic Resonance Spectroscopy; Spectroscopy, Fourier Transform Infrared; Tumor Microenvironment | 2016 |
Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Nitroimidazoles; Paclitaxel; Phosphoramide Mustards; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Mass Spectrometry Imaging of the Hypoxia Marker Pimonidazole in a Breast Tumor Model.
Topics: Biomarkers, Tumor; Breast Neoplasms; Female; Humans; Nitroimidazoles; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Differences in breast tissue oxygenation following radiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Female; Humans; Hyperbaric Oxygenation; Middle Aged; Nitroimidazoles; Oxygen; Skin | 2011 |
A serial study of the concentration of misonidazole in human tumors correlated with histologic structure.
Topics: Adenocarcinoma; Biopsy; Breast Neoplasms; Female; Humans; Male; Misonidazole; Necrosis; Nitroimidazoles; Radiotherapy Dosage | 1981 |
The concentration of desmethylmisonidazole in human tumours and in cerebrospinal fluid.
Topics: Breast Neoplasms; Female; Humans; Misonidazole; Necrosis; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors; Uterine Cervical Neoplasms | 1981 |
[Clinical experience with daily doses of misonidazole (author's transl)].
Topics: Adult; Aged; Breast Neoplasms; Female; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Misonidazole; Nervous System; Nitroimidazoles; Time Factors | 1980 |
Development of new markers for hypoxic cells: [131I]Iodomisonidazole and [131I]Iodoerythronitroimidazole.
Topics: Animals; Breast Neoplasms; Cell Hypoxia; Female; Iodine Radioisotopes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radionuclide Imaging; Rats; Rats, Inbred F344; Tissue Distribution; Tumor Cells, Cultured | 1996 |
New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Movement; Drug Design; Electrochemistry; Female; Hypoxia; Leukocytes, Mononuclear; Lung Neoplasms; Macrophages; Mice; Mice, Inbred C3H; Models, Molecular; Neoplasm Metastasis; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Structure-Activity Relationship; Tumor Cells, Cultured | 2001 |
Distribution of misonidazole in human tumours and normal tissues.
Topics: Brain Neoplasms; Breast Neoplasms; Female; Genital Neoplasms, Female; Humans; Male; Misonidazole; Neoplasms; Nitroimidazoles; Thyroid Diseases; Tissue Distribution; Urinary Bladder Neoplasms | 1979 |
2-phenylindole-linked nitroimidazoles as potential radiosensitizers for estrogen receptor positive tumors.
Topics: Animals; Breast Neoplasms; Cell Division; Female; Humans; Indoles; Mice; Neoplasms, Hormone-Dependent; Nitroimidazoles; Radiation-Sensitizing Agents; Receptors, Estrogen; Tumor Cells, Cultured; Uterus | 1990 |
The uptake of the radiosensitizing compound Ro 03-8799 (Pimonidazole) in human tumors.
Topics: Breast Neoplasms; Female; Humans; Melanoma; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Rectal Neoplasms; Uterine Cervical Neoplasms | 1989 |